1. HBW Insight

Perrigo's Omega Pharma Struggles In 2018 As It Continues To Restructure And Divest

 
• By Tom Gallen

Perrigo's Europe-focused consumer health business Omega Pharma found sales growth hard to come by in 2018 as the group worked hard to right size the organization. While it still has a way to go to completely turnaround Omega, Perrigo is starting to see these interventions pay off, with profits up for the 12 months. 

Nytol Heerbal
Omega Pharma's Nytol Herbal Sleep Aid • Source: Perrigo

Continued efforts by Perrigo Co. PLC to restructure and right-size its Omega Pharma NV consumer health operation hit sales at the Europe-focused business in 2018, with turnover down by 5% for the 12 months.

Perrigo blamed the single-digit slide in Omega’s sales to €988m on the termination of “unprofitable” distribution contracts in Belgium and Portugal, the divestiture of its Russian business to Alvogen Inc

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Earnings

More from Business